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Aims Toexamine theutilityof 18F-fluorodeoxyglucosepositronemission tomography/computed tomography (18F-FDGPET/CT)
in the early diagnosis of cardiac implantable electronic device (CIED) generator pocket infection.
Methods
and results
A total of 86 patients with CIEDswere evaluatedwith 18F-FDGPET/CT imaging: 46with suspected generator pocket infec-
tion and 40without any history of infection. 18F-FDG activity in the region of the generator pocket was expressed as a semi-
quantitative ratio (SQR)—defined as the maximum count rate around the CIED divided by the mean count rate between
normal right and left lung parenchyma. All patients underwent standard clinical management, independent of the PET/CT
result. Patients with suspected generator pocket infection that required CIED extraction (n ¼ 32) had significantly higher
18F-FDG activity compared with those that did not (n ¼ 14), and compared with controls (n ¼ 40) [SQR: 4.80 (3.18–
7.05) vs. 1.40 (0.88–1.73) vs. 1.10 (0.98–1.40), respectively; P, 0.001]. On receiver operator characteristic analysis, SQR
had a high diagnostic accuracy (area under curve¼ 0.98) for the early identification of patients with confirmed infection
(i.e. those ultimately needing extraction)—with anoptimal SQRcut-off value of.2.0 (sensitivity¼ 97%; specificity¼ 98%).
Conclusion This study highlights the potential benefits of evaluating patients with suspected CIED generator pocket infection using
18F-FDG PET/CT. In this study, 18F-FDG PET/CT had a high diagnostic accuracy in the early diagnosis of CIED generator
pocket infection, even where initial clinical signs were underwhelming.
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Introduction
Expanding clinical indications have resulted in increasing numbers of
patients being treated with a cardiac implantable electronic device
(CIED).Despite improved surgical techniques and the useof prophy-
lactic antimicrobial therapy, the number of CIED infections is
increasing disproportionately to the rate of implantation, and this
represents a major healthcare challenge.1,2 Between 2004 and
2006, there was a 57% increase in the rate of hospitalizations for
CIED infection.1
CIED infections may be categorized into those that are associated
with endocarditis (CIED-IE) or lead infections (CIED-LI), and those
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that are confined to the generator pocket (CIED-GPI). Patients with
CIED-IE/LI typically present with signs of systemic illness and usually
have abnormal blood markers for infection.3 Approximately 70% of
patients with CIED infection present with overt infective signs in the
region of the generator pocket (impending or completed device exter-
iorization, abscess formation, and purulent discharge), and in these
patients, the need for extraction without additional investigation is
well established.4,5 However, the clinical presentation of CIED-GPI
is highly variable and patients may also present with only mild loca-
lized signs (pain,withorwithout subtle erythema) posing a diagnostic
challenge as these symptoms can be attributed to both infective and
non-infective causes. Nevertheless, delays in diagnosing and treating
generator pocket infection can result in progression toCIED-IE/LI or
severe sepsis, and thereforeworse clinical outcomes.5,6 Accordingly,
a non-invasive testwith sufficient sensitivity and specificity to confirm
or exclude infection in cases with a low or intermediate pre-test
probability of infection at initial presentation would be desirable.
18F-Fluorodeoxyglucose positron emission tomography with
combined computed tomography (18F-FDG PET/CT) has been
used in the investigation of malignancy for over a decade. More re-
cently, it has been utilized as a diagnostic tool in infection. Early
studies into the utility of 18F-FDG for CIED infection have been
mostly limited to the evaluation of individuals known to have ‘con-
firmed’ or high probability of CIED infection, i.e. subject to spectrum
bias.Data areparticularly lacking for the utility of 18F-FDGPET/CT to
evaluate patients with mild symptoms and signs that are confined to
the generator pocket. Accordingly, we sought to examine the utility
of 18F-FDG PET/CT in the early diagnosis of CIED-GPI across all
pre-test probability groups.
Methods
Design and subjects
A prospective observational study of consecutive patients aged 18 and
over referred to the Manchester Heart Centre with suspected
CIED-GPI between December 2012 and May 2014 who underwent
18F-FDG PET/CT examination. The control group comprised patients
with chronically implanted CIED undergoing 18F-FDG PET/CT for malig-
nancy surveillance, but without clinical evidence of generator pocket or
systemic infection. Patients satisfying Duke criteria for possible or definite
CIED-IE/LI or those with echocardiographic evidence of CIED-IE/LI were
excluded. All patients gave informed consent for 18F-FDGPET/CT assess-
ments and the institutional review board approved the study protocol.
Clinical assessment
All suspectedCIED-GPI caseswere reviewedandexaminedbyanexperi-
enced consultant cardiologist specializing in device extraction (A.M.Z.,
.10 years experience). Baseline evaluation included (i) clinical assess-
ment for signs and symptoms of CIED infection; (ii) grading of erythema
in the region of the generator pocket according to a Clinical Erythema
Assessment (CEA) Scale7 [0 ¼ clear of erythema, 1 ¼ almost clear of
erythema (slight redness), 2 ¼ mild erythema (definite redness), 3 ¼
moderate erythema (marked redness), 4 ¼ severe erythema (fiery
redness); (iii) bloodmarkersof infection, including three setsof bloodcul-
tures, full blood count and C-reactive protein (CRP); and (iv) standard
transthoracic echocardiography performed in accordance with ESC/
EACVI guidelines.8 Where possible, the blood cultures were obtained
before antimicrobial therapy was commenced.
Possible vs. definite CIED-GPI
Patients were divided into ‘possible’ or ‘definite’ CIED-GPI groups
according to specific clinical criteria. ‘Possible’ CIED-GPI (Group 1)
was defined as localized pain in the region of the generator pocket with
or without slight (CEA grade 1) erythema of the overlying skin. ‘Definite’
CIED-GPI (Group2)wasdefined as significant erythema (CEAgrade 2or
above) in the regionof the generator pocket, abscess formation, purulent
discharge or wound dehiscence or erosion; with or without positive
blood cultures, butwithout evidence of lead or endocardial involvement,
according to published guidelines.9–11
18F-FDG PET/CT scanning was performed in all cases and controls
according to the same protocol. Figure 1 illustrates the study protocol.
All patients with ‘definite’ infection underwent extraction; in patients
with ‘possible’ infection the decision to undergo extraction or not was
made after further clinical review by the same cardiologist (A.M.Z., .10
years experience inCIEDmanagement) on the basis of persistenceor pro-
gressionof thesymptomsand/or signs.Although therewasno formal blind-
ing from the PET/CT results, the cardiologist was instructed to manage
patients as per their usual clinical practice. For those patients undergoing
device extraction, samples were sent for microbiological analysis.
18F-FDG PET/CT scanning protocol
All subjects were fasted for 4–6 h prior to the scan. A blood glucose of
3.5–12 mmol/L at the time of study was achieved. 18F-FDG PET/CT
imagingwas performed using a Siemens BiographmCT (SiemensHealth-
care) with an extended axial field of view (TrueV). A low-dose CT scan
was obtained for attenuation correction (AC) of the PET images, which
were acquired in 3D mode at 2.5 min per bed position between 60 and
90 min post-injection of 350–400 MBq 18F-FDG.
18F-FDG PET/CT image analysis
Imageswere viewed using Volumetrix software on aGEXeleris worksta-
tion (GE Healthcare). All images were analysed by an experienced
nuclearmedicine physician (J.J., 25 years experience) and amedical physi-
cist. Where there was disagreement arbitration was sought from a third
observer (G.A.B., nuclear medicine physician, 14 years experience).
A positive scan was defined by increased FDG activity on the AC PET
images around the device, i.e. maximal standardized uptake value
(SUVmax) greater than mediastinal blood pool activity. A negative scan
was defined as no increased FDG activity around the device relative to
surrounding tissues or mediastinal blood pool. However, definition of a
metric derived from the PET images to quantify the presence and
extent of infection is challenging. In PET CT imaging, streak artefacts on
the CT images from metal implants have the potential to propagate to
the CT-based AC maps causing inaccuracies in the quantification of
tissue tracer uptake in the AC PET images. This is of concern when
trying to quantify uptake of 18F-FDG around a metallic CIED from AC
PET images. Therefore, Sarrazin et al. defined a semi-quantitative ratio
(SQR) derived from count rates in the non-AC PET images12 to circum-
vent any errors in tracer uptake introduced during the AC process. The
SQR is defined as the maximum count rate in the region surrounding the
CIED (and associated leads) to themean count rate between normal left
and right lung parenchyma. Areas of abnormal lung parenchyma were
avoided in the analysis.
Surgical technique and collection
of microbiological samples
Where the CIED system was extracted the operative technique for col-
lection of samples was standardized and performed by a highly experi-
enced cardiologist specializing in CIED extraction (A.Z., .10 years
experience). Upon opening the pocket any pus was aspirated using a
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sterile syringe; 1–3 mL of pus was injected into a paediatric FAN blood
culture bottle (Biomerieux, UK) and a further charcoal swab was
obtained. Where there was no fluid or pus present, sterile saline was
introduced into the pocket following removal of the pulse generator
and the washings were sent for microbial analysis. Samples of superficial
tissue from the pocket (at the incision site) and deep tissue (from the
floor of the pocket) were obtained and sent for microbial analysis.
Finally, extravascular portions of the leadwere cut and sent for microbial
analysis before the intravascular portion of the lead was extracted.
All leads were extracted transvenously via the subclavian or femoral
routes. Lead tips were also sent for analysis. Each organism isolated
was reported to species level with appropriate sensitivity results.
Direct sensitivity testing was performed using the British Society for
Antimicrobial Chemotherapy (BSAC) standards.13
Statistical analysis
Statistical analyseswereperformedusingRversion2.15.2. (librariespsych,
epiR, and epicalc).14–17 Data are presented as median (IQR) or N (%)
as appropriate. Group medians were compared a Mann–Whitney
U-test or Kruskall–Wallis test (multiple groups) as appropriate. Categor-
ical datawerecomparedusing Fisher’s exact test. Receiveroperating char-
acteristic (ROC) analysis was performed to determine the diagnostic
accuracy of SQR to detect (i) possible or definite infection (as per
pre-test clinical criteria), (ii) definite infection (as per pre-test clinical cri-
teria), and (iii) the clinical need for extraction, i.e. confirmed CIED-GPI
(using eventual clinical course as the reference standard). Optimal SQR
thresholds from the ROC curve were determined using the maximum
Youden index (J ¼ sensitivity + specificity2 1).All testswere two-tailed
and P, 0.05 was considered statistically significant.
Results
Study population
In total, 86 patients with CIEDs were evaluated with 18F-FDG PET/
CT imaging: 46 with suspected CIED-GPI and 40 controls without
any historyof infection. Further demographic information and clinical
presentation are presented in Tables 1 and 2, respectively.
Figure 1 Clinical protocol for assessment and management of patients with suspected CIED generator pocket infection.
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Table 2 Clinical presentation and laboratory markers for infection in patients with suspected CIED infection
Group 1 (n5 26) Group 2 (n5 20) P
Presentation
Fever, n (%) 1 (4) 3 (15) 0.303
Device erosion, n (%) 0 (0) 5 (25) 0.011
Abscess, n (%) 0 (0) 6 (30) 0.004
Purulent discharge, n (%) 0 (0) 2 (10) 0.184
Mild swelling, n (%) 1 (4) 0 (0) 0.467
Localized pain, n (%) 24 (92) 6 (30) ,0.0001
Erythemaa, n (%) 6 (23) 7 (35) 0.748
Grade 1 6 0 0.029
Grade 2 0 2 0.1836
Grade 3 0 3 0.075
Grade 4 0 2 0.184
Blood markers of infection
Median WCC (IQR) 7.5 (6.6–8.3) 7.2 (6.2–9.1) 0.407
Elevated WCC, n (%) 2 (8) 2 (10) 1.000
Median CRP (IQR) 2.0 (1.5–11.0) 2.0 (2.0–5.5) 0.084
Elevated CRP, n (%) 5 (19) 4 (20) 1.000
Positive blood cultures, n (%) 0 (0) 1 (5) 0.435
Device-related factors
Median time (days) from last procedure to presentation (IQR) 309 (121–1245) 1385 (128–2667) 0.113
Generator replacement or revision within 12 months, n (%) 6 (23) 4 (20) 1.000
Site revision within 12 months, n (%) 1 (4) 2 (10) 0.572
Median length (days) of in-patient stay (IQR) 0 (0–2) 18 (8–29) ,0.0001
Median length in-patient stay (days) for infected cases (IQR) 5 (1–17) 18 (8–29) 0.036
Pre-treatment with antimicrobials before PET/CT (receiving antibiotics at time of PET/CT
examination)
8 (31) 18 (90) 0.0002
Median duration of antimicrobial therapy (days) before PET/CT examination (IQR) 0 (0–8) 14 (7–14) 0.0001
WCC, white cell count; CRP, C-reactive protein.
aClinical Erythema Assessment Scale.
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Table 1 Demographics of study participants
Group 1: ‘Possible’
infection (n 5 26)
Group 2: ‘Definite’
infection (n5 20)
P
Male sex, n (%) 18 (69) 15 (75) 0.408
Median age, years (IQR) 61.0 (52–80) 65.6 (57–80) 0.176
Device Type
PPM, n (%) 17 (65) 8 (40) 0.136
ICD/CRT-D, n (%) 9 (35) 12 (60) 0.136
Co-morbidities
Median age-adjusted Charlson index (IQR) 2 (0–3) 4 (2–5) 0.136
Adult congenital heart disease, n (%) 3 (12) 2 (10) 1.000
Diabetes, n (%) 3 (12) 3 (15) 1.000
Chronic kidney disease stage ≥3, n (%) 3 (12) 3 (15) 1.000
PPM, permanent pacemaker; ICD, implantable cardioverter defibrillator; CRT-D, cardiac resynchronization therapy-defibrillator.
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Clinical outcome
Of the 46 patients with suspected CIED-GPI, 26 were categorized as
‘possible’ infection (Group 1) and 20 as ‘definite’ infection (Group 2)
based on the specified clinical criteria.
Group 1
Of the 26 patients inGroup 1 (‘possible’ infection), 12were ultimately
considered to have CIED-GPI based on their clinical progression
which led toCIEDextraction.An additional patient, originally consid-
ered as a ‘possible’ case of CIED-GPI, did not undergo extraction
because the symptoms in the region of the pocket had completely
resolved at subsequent clinical review—this patient also had a
positive PET/CT result (SQR 2.6). The latter was considered to
be a ‘false positive’ given clinical resolution with conservative
management but the possibility of a self-limiting infection remains.
A follow-up 18F-FDG PET/CT assessment in this individual per-
formed 3 months later for evaluation of a suspicious left upper
lobe lung lesion identified on the original scan, subsequently demon-
strated a reduction in SQR (1.7) in the region of the CIED generator
pocket. We continue to closely monitor this individual for signs of
infection.
The remaining 13 patients inGroup 1 remainedwell during clinical
follow-up [237 (129–384) days] with no crossover to extraction and
were all found to have a normal 18F-FDG PET/CT result.
Group 2
All 20 (100%) patients in Group 2 (‘definite’ infection) underwent
system extraction as planned. Seventeen of these patients were
found to have a positive 18F-FDGPET/CT result (see Supplementary
data online).
Localized erythema
While the intensityof erythema in the regionof the generator pocket
between the two groups was visually distinct (P ¼ 0.029, Table 2),
18F-FDG uptake within the CIED pocket was increased in all 13
patients with erythema (grade 1–4) that we examined (Table 3).
11/13 (84.6%) cases had microbiological evidence of infection
(Group 1, n ¼ 4, Group 2, n ¼ 7).
Localized pain only
Out of the 18 patients who presented with lone pain in the region of
the generator pocket, 6 (33.3%) had abnormal 18F-FDG PET/CT
scans (Figure 2). A pathogen was recovered from three of these six
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Table 3 Profile and infective status of individual patients in Group 1
Episode Presentation 18F-FDG result SUVmax SQR around CIED Outcome
1 Grade 1 erythema and pain Positive 2.1 2.4 Extracted
2 Grade 1 erythema and pain Positive 7.1 6.7 Extracted
3 Grade 1 erythema and pain Positive 4.9 8.3 Extracted
4 Grade 1 erythema and pain Positive 7.8 6.4 Extracted
5 Grade 1 erythema Positive 7.5 9.4 Extracted
6 Grade 1 erythema Positive 4.9 6.6 Extracted
7 Pain Positive 4.7 4.7 Extracted
8 Pain Positive 4.9 4.5 Extracted
9 Pain Positive 5.1 4.7 Extracted
10 Pain Positive 3.4 3.0 Extracted
11 Pain Positive 3.6 6.6 Extracted
12 Pain Positive 2.8 3.2 Extracted
13 Pain and mild swelling. Signs completely resolved
at re-review. Incidental LUL lesion on PET
Positive 2.5 2.6 Not extracted
14 Pain and fever Negative 1 1.1 Not extracted
15 Pain Negative 1.3 0.8 Not extracted
16 Pain (ACHD, multiple generator changes) Negative 1.3 1.5 Not extracted
17 Pain Negative 1.2 0.5 Not extracted
18 Pain Negative 2.0 1.8 Not extracted
19 Pain (ACHD) Negative 1.3 1.8 Not extracted
20 Pain (ACHD) Negative ,1.0 0.7 Not extracted
21 Pain Negative 1.4 1.8 Not extracted
22 Pain Negative 1.4 1.3 Not extracted
23 Pain Negative 1.1 1.2 Not extracted
24 Pain Negative 1.2 0.6 Not extracted
25 Pain Negative 1.3 1.1 Not extracted
26 Pain Negative 1.5 1.5 Not extracted
ACHD, adult congenital heart disease; LUL, left upper lobe.
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cases (50%). In contrast, the patients who presented similarly with
localized pain but had negative 18F-FDG PET/CT findings (n ¼ 12)
were managed successfully with a conservative strategy.
SUVmax
Increased 18F-FDG uptake (SUVmax) in the region of the generator
pocket was seen in 85% (n ¼ 17) of Group 2 (‘definite’ infection)
patients compared with 50% (n ¼ 13) of Group 1 (‘possible’ infec-
tion) patients. No control cases showed increased 18F-FDG uptake
in the region of the generator pocket.
In thoseGroup1patientswithout increased 18F-FDGuptake in the
region of the pocket (n ¼ 13, 50%), there was also no increase any-
where along the visualized length of the leads (Figure 3).
SQR
Overall, SQR was significantly higher in those cases that required
extraction (n ¼ 32) compared with those that were successfully
managed conservatively (n ¼ 14), and compared with controls
(n ¼ 40) [SQR: 4.80 (3.18–7.05) vs. 1.40 (0.88–1.73) vs. 1.10
(0.98–1.40) respectively; P, 0.001] (Figures 4 and 5).
Amongst those initially assessed as only ‘possible’ infection, i.e.
Group 1 (n ¼ 26), the SQR was also significantly higher in those
that ultimately required CIED extraction (n ¼ 12) compared with
those that did not (n ¼ 14) [4.75 (4.18–6.62) vs. 1.40 (0.88–1.73);
P, 0.001].
SQR thresholds
SQR had a high diagnostic accuracy to identify confirmed CIED-GPI
(defined by eventual clinical need for extraction), and the optimal
threshold was .2.0 [97% sensitivity (84–100%), specificity 98%
(90–100%), area under the curve (AUC) ¼ 0.98, J ¼ 0.95].
The optimal threshold for differentiating suspected CIED-GPI
(‘possible’ or ‘definite’ infection) from controls was a SQR .1.75
[sensitivity 76% (61–87%), specificity 100% (87–100%), AUC ¼
0.88, J ¼ 0.76]; and the optimal threshold to differentiate only
those categorized as ‘definite’ infection from the rest was
Figure2 Example of a positive 18F-FDGPET/CT scan in aGroup 1 individual with pain at the generator pocket site. (A) Increased 18F-FDGuptake
is seen in the region of the left pre-pectoral pocket on the coronal views (yellow arrows). (B) In the sagittal plane, increased 18F-FDG uptake can be
seen on the muscular aspect of the pre-pectoral generator (yellow arrows) and along the proximal portion of the leads (red arrows). (C) Increased
18F-FDG uptake visualized on the muscular aspect of the generator pocket (yellow arrows).
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SQR .1.9 [sensitivity 95% (75–100%), specificity 80% (69–89%),
AUC ¼ 0.88, J ¼ 0.75].
Microbiological analysis
Of the 32 cases (from both Groups 1 and 2) that underwent extrac-
tion, a pathogen was identified in 26 (81.3%) cases. Out of the 12
cases from Group 1 undergoing extraction, 7 had microbiological
evidence of infection. In four cases, no pathogen was recovered
from any of the samples analysed; in the remaining case a pathogen
could not be sought due an error in specimen collection. In Group 2,
microbiological evidence of infection was available for 19 out of 20
cases. In one individual, there was no growth from any of the recov-
ered specimens.
Discussion
This study is the largest prospective evaluation of 18F-FDG PET/CT
for suspected CIED-GPI and examines its role across a full spectrum
of presentations ranging from peri-pocket persistent pain to pocket
abscess and device exteriorization. The two main findings are that
(i) 18F-FDG activity is significantly higher in patients who ultimately
require CIED extraction compared with those who resolve with
conservative treatment or compared with normal controls; and
(ii) 18F-FDG activity has a high diagnostic accuracy (AUC ¼ 0.98)
for the early identification of patients ultimately needing extraction,
using an optimal SQR cut-off value of .2.0.
In this study, we have demonstrated the utility of 18F-FDGPET/CT
in the early diagnosis of CIED-GPI when the clinical diagnosis is
unclear due to mild symptoms that could be attributed to either
infective or non-infective causes. This is of particular clinical import-
ance as pain, with or without subtle erythema, in the region of the
generator pocket is a frequent complaint of patients seen in CIED
follow-up clinics.5 At present it is unclear what proportion of these
patients have subclinical infection thatwill progress over time, result-
ing in more severe complications.
Sarrazin et al. have previously reported that 18F-FDG PET/CT is
useful in differentiating between individuals with CIED infection
(not just pocket infection) and recent post-implant changes.12
Figure 3 Example of a negative 18F-FDG PET/CT scan in a Group 1 patient who presentedwith pain at the generator pocket site. This individual,
with a history of grown up congenital heart disease and 20-year-old right-sided pacing leads (episode 16), presented with pain in the region of their
right pre-pectoral pocket 4 years after generator box change. There is no evidence of increased 18F-FDG uptake in the region of the right-sided
generator pocket (green arrows) or along the proximal portion of the leads (A, B and C).
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However, such previous studies have, for themost part, only exam-
ined individuals with knownCIED-GPI or a high pre-test probability
and are therefore limited by a spectrum bias.12,18,19 Individuals with
mild local symptoms and a lower pre-test probability of infection at
presentation have not been examined. Therefore, by including
patients with a pre-test clinical assessment of suspected but
not proven ‘possible’ CIED-GPI (n ¼ 26) as well as those with a
pre-test clinical assessment of ‘definite’ CIED-GPI, the current
study includes a full spectrum of risk and is more applicable to real-
world practice.
In this study, FDG PET/CT imaging had a high diagnostic accuracy
(AUC ¼ 0.98) for the early identification of patients ultimately
needing extraction, using an optimal SQR cut-off value of.2.0 (sen-
sitivity 97%, specificity 98%). This may help guide a strategy of early
extraction vs. futile conservative management—even in patients
who initially present with only mild localized signs, or where the
infective status is not immediately clinically obvious.
In this study, we also compared FDG PET/CT imaging to standard
pre-test clinical assessment by an experienced cardiologist specializ-
ing in CIED management. The high diagnostic accuracy of FDG PET/
CT to distinguish possible or definite pre-test probability CIED-GPI
groups from controls (AUC ¼ 0.88) or to distinguish the definite
pre-test probability CIED-GPI group from all other groups
(AUC ¼ 0.88) open up the possibility of FDG PET/CT imaging
being used where a specialist opinion and clinical assessment is not
immediately available—as a means of stratifying ‘definite’ cases for
prompt referral to specialist centres for early extraction. Prompt
diagnosis of non-valvular CIED infections is of paramount clinical
importance as failure to do so can delay extraction and result in
endovascular spread of infection or endocarditis associated with
significant morbidity and mortality.11,20,21 Early and complete CIED
removal, on the other hand, is associated with improved 30 day
and 1 year outcomes.20 Despite this, delays in CIED extraction in
favour of surveillance and a trial of antimicrobial therapy are not
uncommon practice.
Our results also offer insight into the relative importance of subtle
signs such as localized erythema and lone pain. We suggest that the
presence of erythema (of any grade) in patients with suspected
CIED-GPI should be considered a red-flag clinical sign. On the
other hand, in our study, 12 the patients who presented with only
localized pain had negative 18F-FDG PET/CT findings (n ¼ 12) and
were successfully managed with a conservative strategy. Therefore,
localized pain alone may more commonly relate to non-infective
pathology, such as superficial placement of the device in the
absence of infection and a negative 18F-FDG PET/CT could be used
to offer reassurance in this group.
In summary, optimal decision-making in patients with suspected
CIED-GPI requires an assessment of the probability of infection.
We believe our results show that an imaging-based approach
would be helpful in patients with low and intermediate probability
of CIED-GPI when there are subtle clinical signs and normal blood
markers for infection.
Correct identification of microbial pathogens is essential for
the targeted treatment of CIED infections. Nevertheless, microbio-
logical confirmation of infection is not a pre-requisite for the diagno-
sis of CIED-GPI,9,11 because the diagnosis is based on clinical criteria.
Culture-negativecasesofCIEDpocket infections arewell recognized
and have been reported to occur in up to 16% of patients.22 There-
fore, negative culture results cannot be used to rule out a diagnosis
of infection. There were five cases of culture-negative CIED pocket
infection in our series (Group 1, n ¼ 4; Group 2, n ¼ 1, Table 4).
Three of these cases were pre-treated with antimicrobials prior to
CIEDextraction (Group1, n ¼ 2;Group 2, n ¼ 1). Reasons for nega-
tive cultures include empirical antimicrobial therapy prior to culture
Figure4 18F-FDGuptake inpatientswith suspectedCIEDgener-
ator pocket infection. Individuals in Group 1 (n ¼ 26) and Group 2
(n ¼ 20) underwent 18F-FDGPET/CTassessment. 18F-FDGuptake
in the regionof the generator pocket, as expressed by the SQR,was
lower in Group 1 than Group 2 [SQR 2.10 (1.28–4.73) vs. 4.90
(2.80–7.73), P ¼ 0.003]. Lines represent median values. Unfilled
circles illustrate the patients whose clinical symptoms resolved
and were managed conservatively (n ¼ 14).
Figure 5 18F-FDG uptake in extracted cases, non-infected cases
and controls. SQR was significantly greater in patients who under-
went extraction (n ¼ 32) than in non-infected cases (n ¼ 14) and
controls (n ¼ 40) [SQR 4.80 (3.18–7.05) vs. 1.40 (0.88–1.73) vs.
1.10 (0.98–1.40) respectively; P, 0.001]. There was no significant
difference in SQR between non-infected cases and controls.
Unfilled circles illustrate subjects presentingwith pre-test ‘possible’
infection (Group 1). Lines represent median values.
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of extracted samples, inappropriate culture techniques, and difficult
to culture or non-culturable pathogens.
Limitations
The current study has some key limitations. First, the use of antibio-
tics prior to PET/CT examination and extraction in 26 patients may
have impacted on both 18F-FDG uptake and recovery of pathogens
from extracted samples. Antibiotic therapy has been shown to
cause a significant decrease in 18F-FDG uptake in other conditions.23
However, this puts our results into real-world context as it is
common practice for antibiotics to be given by primary care givers
and emergency departments on first contact. In the current study,
three Group 2 patients (‘definite’ infection at initial presentation)
had no increased 18F-FDG activity in the region of the device
pocket [maximal standardized uptake value (SUVmax) less thanmedi-
astinal blood pool activity]. Two of these were managed with pro-
longed courses of antibiotics before onward referral to our centre
for extraction. While two of the three patients had an SQR .1.75,
one patient (draining sinus, prolonged antibiotic treatment) had an
SQRof 0.6. This casewas considered a ‘false negative’. It is postulated
that chronic antimicrobial therapy was a significant contributing
factor to the negative PET/CT result in this case. All remaining
patients who underwent extraction and received prior treatment
with antimicrobials (n ¼ 24) had increased 18F-FDG uptake in the
region of the device pocket (SQR .2.0).
Although the majority of subjects were referred to our centre
from other hospitals, PET/CT examinations and extraction proce-
dureswere all performedat a single centre. Thiswas anobservational
study. PET/CTwasnot used to guide thedecision toextractorother-
wise. The decision to proceedwith extractionwasmade on standard
clinical criteria, i.e. the persistence and/or progression of clinical
symptoms and signs of infection. This decision was made by the
same cardiologist in all cases. Although the clinician was not formally
blinded to the FDG PET/CT results, they were instructed to act as
per their usual clinical practice andwithout bias from imaging findings.
Despite best intentions, we concede it is possible that knowledge of
the FDG PET/CT result (positive or negative, but not the SUVmax or
SQR) may have influenced clinical decisions. In particular, a negative
FDG PET may have potentially re-inforced the decision to adopt a
conservative strategy in those Group 1 individuals whose clinical
symptoms and signs were not debilitating or did not progress with
time. However, as testament to the cardiologist’s intended lack of
bias we highlight that there was one case with a positive scan
(Group1)whowasmanaged conservatively due to resolutionof clin-
ical signs. Our data require validation in larger populations involving
several hundred patients as part of a multi-centre study. Finally, the
utility of PET/CT as a diagnostic tool in cases of CIED infection
remains under investigation. Routineuse of PET/CToutside research
studies is not currently recommended.9
Conclusion
This study highlights the potential benefits of evaluating patients with
suspected CIED-GPI using 18F-FDG PET/CT. In this study, 18F-FDG
PET/CT had a high diagnostic accuracy in the early diagnosis of
CIED-GPI—even where initial clinical signs were underwhelming.
This represents a major step forward in our understanding of the
potential applications of molecular imaging in CIED recipients.
Supplementary data
Supplementary data are available at European Heart Journal—
Cardiovascular Imaging online.
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